HealthCNBC Techabout 2 hours ago
Thyme Care raises $125M, valuation tops $2B
1 min read
Thyme Care raised $125 million in a Series E led by Morgan Health, doubling its valuation to over $2 billion. The cancer care startup will form Thyme Companies to address drug affordability and clinical trial access. Services reach 10.5 million people across all 50 states.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
